| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Bernard Fromenty | |
| Gilles Labbe | |||
| Dominique Pessayre | |||
| P2860 | cites work | Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion | Q34689211 |
| Perhexiline | Q36795930 | ||
| Mitochondrial damage associated with long-term antiretroviral treatment: associated alteration or causal disorder? | Q40621030 | ||
| Immunological study of the tissue expression of D-beta-hydroxybutyrate dehydrogenase, a ketone body-converting enzyme | Q48255495 | ||
| P433 | issue | 4 | |
| P921 | main subject | mitochondrion | Q39572 |
| P304 | page(s) | 335-353 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Fundamental and Clinical Pharmacology | Q15760364 |
| P1476 | title | Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies | |
| P478 | volume | 22 |
| Q39483338 | A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver |
| Q43528067 | A high content screening assay to predict human drug-induced liver injury during drug discovery |
| Q46364739 | A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis |
| Q42707141 | A simple transcriptomic signature able to predict drug-induced hepatic steatosis. |
| Q46408637 | Allicin enhances chemotherapeutic response and ameliorates tamoxifen-induced liver injury in experimental animals |
| Q37706542 | Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice |
| Q57037050 | Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice |
| Q42354312 | CSH guidelines for the diagnosis and treatment of drug-induced liver injury |
| Q26749054 | Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury |
| Q30278737 | Chronic liver injury induced by drugs: a systematic review. |
| Q34668643 | Comparative proteomics study on liver mitochondria of primary biliary cirrhosis mouse model |
| Q55920548 | DeepTox: Toxicity Prediction using Deep Learning |
| Q37251993 | Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue. |
| Q55345230 | Drug-Induced Liver Injury: An Institutional Case Series and Review of Literature. |
| Q38845891 | Drug-induced hepatotoxicity in cancer patients - implication for treatment |
| Q56541717 | Drug-induced steatohepatitis |
| Q91789694 | Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China |
| Q43181274 | Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. |
| Q41679878 | Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat. |
| Q92604420 | Effects of N-acetyl cysteine, vitamin E and vitamin C on liver glutathione levels following amiodarone treatment in rats |
| Q54937303 | Effects of mid-respiratory chain inhibition on mitochondrial function in vitro and in vivo. |
| Q59132384 | Efficacy of sertraline against : an in vitro and in silico study |
| Q34219621 | Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells |
| Q28069617 | Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man |
| Q64069758 | Experimental observation of mitochondrial oxidative damage of liver cells induced by isonicotinic acid hydrazide |
| Q37756278 | Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening |
| Q34715847 | Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway |
| Q38793908 | High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis |
| Q28479257 | High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria |
| Q58680687 | High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins |
| Q38383132 | High-content screening technology for studying drug-induced hepatotoxicity in cell models. |
| Q34786843 | High-throughput respirometric assay identifies predictive toxicophore of mitochondrial injury |
| Q35781121 | Identification of a Mitochondrial DNA Polymerase Affecting Cardiotoxicity of Sunitinib Using a Genome-Wide Screening on S. pombe Deletion Library |
| Q47093593 | Impairment of Mitochondrial Biogenesis and Dynamics Involved in Isoniazid-Induced Apoptosis of HepG2 Cells Was Alleviated by p38 MAPK Pathway |
| Q42485953 | In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor. |
| Q28552676 | Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice |
| Q90723016 | Limonin: A Review of Its Pharmacology, Toxicity, and Pharmacokinetics |
| Q52610392 | Major role of apolipoprotein B in cycloheximide-induced acute hepatic steatosis in mice. |
| Q35956406 | Mammalian Cells Exhibit a Range of Sensitivities to Silver Nanoparticles that are Partially Explicable by Variations in Antioxidant Defense and Metallothionein Expression |
| Q37557613 | Mechanism-based bioanalysis and biomarkers for hepatic chemical stress. |
| Q33856306 | Mechanisms of immune-mediated liver injury |
| Q38208324 | Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress |
| Q26864710 | Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity |
| Q33954265 | Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria |
| Q90152339 | Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury |
| Q38675826 | Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs. |
| Q38084631 | Mitochondria as a pharmacological target: magnum overview |
| Q92619453 | Mitochondrial DNA Variants in Patients with Liver Injury Due to Anti-Tuberculosis Drugs |
| Q50049868 | Mitochondrial dysfunction induced by leflunomide and its active metabolite |
| Q42720801 | Mitochondrial dysfunction induced by sertraline, an antidepressant agent |
| Q42215667 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes unveiled by valproate |
| Q42959618 | Nonalcoholic steatohepatitis in a patient with ataxia-telangiectasia |
| Q57119333 | Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures |
| Q36051438 | Oxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity. |
| Q42090708 | PharmGKB summary: isoniazid pathway, pharmacokinetics. |
| Q64389174 | Pharmacometabolomics Reveals Irinotecan Mechanism of Action in Cancer Patients |
| Q36247086 | Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria |
| Q42054933 | Protective effects of an ethanol extract of Angelica keiskei against acetaminophen-induced hepatotoxicity in HepG2 and HepaRG cells |
| Q51133492 | Protective role of thymoquinone against liver damage induced by tamoxifen in female rats. |
| Q36119623 | Red Palm Oil Attenuates Lead Acetate Induced Testicular Damage in Adult Male Sprague-Dawley Rats |
| Q93197421 | Role of Kupffer cells in liver injury induced by CpG oligodeoxynucleotide and flucloxacillin in mice |
| Q26765518 | Role of endoplasmic reticulum stress in drug-induced toxicity |
| Q38687132 | Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity |
| Q38268013 | SEURAT-1 liver gold reference compounds: a mechanism-based review |
| Q37529605 | Screening for the drug-phospholipid interaction: correlation to phospholipidosis |
| Q37802944 | Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies |
| Q57067352 | Subchronic Toxicity Studies of Cortex Dictamni Extracts in Mice and Its Potential Hepatotoxicity Mechanisms in Vitro |
| Q36502027 | Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice |
| Q42359107 | Targeted transplantation of mitochondria to hepatocytes |
| Q92241354 | The Beneficial Roles of SIRT1 in Drug-Induced Liver Injury |
| Q44397464 | The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen. |
| Q44060851 | The combination of glutamate receptor antagonist MK-801 with tamoxifen and its active metabolites potentiates their antiproliferative activity in mouse melanoma K1735-M2 cells. |
| Q46272510 | Tools to Measure Cell Health and Cytotoxicity Using High Content Imaging and Analysis |
| Q52981626 | Toxicity of Evodiae fructus on rat liver mitochondria: the role of oxidative stress and mitochondrial permeability transition. |
| Q99201941 | Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? |
| Q36195072 | Zolpidem Use Associated With Increased Risk of Pyogenic Liver Abscess: A Case-Control Study in Taiwan |
Search more.